Abstract
The pharmacokinetic characteristics of brivaracetam are described and the interaction effects of concomitant antiepileptic drugs on brivaracetam in terms of its pharmacokinetics and pharmacodynamics are highlighted.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stockis A, Chanteux H, Rosa M, Rolan P. Brivaracetam and carbamazepine interaction in healthy subjects and in vitro. Epilepsy Res. 2015;113:19–27.
Summary of Product Characteristics: Brivaracetam (Briviact). UCB Pharma Ltd. Last update 21 Jan 2016.
Biton V, Berkovic SF, Abou-Khalil B, Sperling MR, Johnson ME, Lu S. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial. Epilepsia. 2014;55:57–66.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Patsalos, P.N. (2016). Brivaracetam. In: Antiepileptic Drug Interactions. Springer, Cham. https://doi.org/10.1007/978-3-319-32909-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-32909-3_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32908-6
Online ISBN: 978-3-319-32909-3
eBook Packages: MedicineMedicine (R0)